Capacitive Micromachined Ultrasonic Transducer (CMUT) technology, which has been widely studied in the field of medical imaging, possesses strong design flexibility due to its manufacturing process. Many applications could benefit from this unique feature, especially those that require different operating ultrasonic frequencies. This article reports on the characterization of the therapeutic low-frequency field provided by an ultrasound-guided focused ultrasound CMUT probe that is connected to a custom ultrasonic scanner for hyperthermia applications. The study begins by mapping the focused ultrasonic beam in the vicinity of the focal spot and a parametric analysis providing the maximum peak-to-peak (PTP) pressure delivered by the probe under different acoustic conditions. The measured maximum PTP pressure at the targeted operating frequency of 1 MHz is 3 MPa, with a maximum of 3.6 MPa at 1.25 MHz. Based on an in vitro setup found in the literature, the temperature elevation at the focal point was measured, showing results in agreement with the targeted applications (max. ∆T = 7.5˚C). The article concludes with a reliability study considering the delivered pressure and the self-heating of the CMUT probe: the results show the good stability of the pressure amplitude over 1.8 × 10 9 cycles at a duty cycle of 40%, with a moderate internal heating of 3˚C.
Introduction
Alongside the well-known use of high-amplitude ultrasonic sequences for ablative purposes, the scientific community is experiencing an exciting era in the development of new therapeutic protocols, for which ultrasonic waves are exploited in a more indirect way. In particular, the targeted drug delivery field, which is being increasingly promoted to reduce drugs side effects and improve the treatment efficiency, is widely benefiting from this keen interest in therapeutic ultrasound. Among the most common applications that are still under development or close to mature exploitation, one can mention drug and gene transfection [1] [2], transdermal drug delivery [3] , and the disruption of the blood-brain barrier [4] . Generally, the operating frequency is quite far below the diagnostic imaging frequency, in the range from a few tens of kilohertz up to a few megahertz, with the most commonly used region around 1 MHz [5] . Most of these new therapeutic approaches still need deep maturation through preclinical testing on small animals.
Therapy involves prior diagnosis and scrupulous treatment guidance. Historically and for several legitimate motivations, magnetic resonance imaging (MRI) is often used to achieve these requirements. MRI provides high-quality images with significant ease of tissue heat monitoring. The development of new devices and protocols, referred to as magnetic resonance guided focused ultrasound (surgery) (MRgFUS) [6] [7] , has resulted from this natural combination. However, magnetic resonance imaging is not free from drawbacks: important aspects include the cost, safety issues related to magnetic fields and ferromagnetic objects, and the dependence on the patient's condition. For these reasons, ultrasonic guidance may be more suitable in some cases: ultrasonic imaging is cheap, fast and easy to use and provides real-time images. Therefore, ultrasound guided focused ultrasound devices (USgFUS) [8] have regained the interest they had lost with the advent of MRgFUS.
For all these reasons, our group has undertaken the development of a USgFUS probe dedicated to the maturation of targeted therapy protocols on small animals. The main originality of this probe is the use of CMUT (capacitive micromachined ultrasonic transducer) arrays instead of the classical piezoelectric transducers. A CMUT transducer is a microelectromechanical chip made of hundred/thousands of microscale membranes driven by electrostatic forces.
Presented for the first time in 1994 by Haller and Khuri-Yakub [9] , CMUT transducers have been deeply studied for ultrasonic imaging purposes [10] - [15] until the recent first international commercialization of a CMUT linear probe [16] . Several studies have also assessed the potential benefits of CMUT arrays for therapeutic intents, but all have been strictly circumscribed to high-intensity focused ultrasound (HIFU) [17] [18] [19] [20] [21] . Additionally, these studies have generally considered only the early stage of development and characterization, whereas the complete functionality of a fully packaged CMUT-based probe for FUS applications still needs to be demonstrated. This is one of the goals of D. Gross et al. Open Journal of Applied Sciences this paper. CMUT transducers seem to provide significant benefits over the state-of-the-art piezoelectric transducers. First, their intrinsically low mechanical losses [22] result in low spurious self-heating of the probe and thus the potential ability to execute high duty cycle (DC) therapeutic sequences without the need for an external cooling system. Furthermore, the thickness of the material fixes the operating frequency for piezoelectric transducers, making the conception of an USgFUS probe embedding two different types of transducer difficult, as the designers have to deal with different transducer sizes depending on their operating frequency. This issue is naturally exacerbated when the imaging and therapeutic frequencies are quite far from each other. Significant developments based on this approach have nevertheless been reported in the literature, with promising results [23] [24] [25] . Sometimes, USgFUS designers prefer to use so-called "dual-mode transducers", which often means to focus on one of the two modalities at the expense of the other: for instance, [8] primarily designed their USgFUS probe with therapeutic considerations, and methods were later investigated to obtain satisfying images [26] . Nevertheless, these solutions are only applicable to situations in which the imaging and therapeutic frequencies are quite close to each other to deal with the relatively narrow bandwidth of piezoelectric transducers. On the other hand, CMUT transducers are much more flexible in this respect because of their well-known large bandwidth and the possibility of easily incorporating two completely different types of transducer side by side by simply scaling the size of the membranes. Furthermore, as they are based on microelectromechanical systems, CMUT transducers provide an extremely high degree of compactness and packaging. Therefore, high-end probes including multi-frequency compact arrays are achievable using CMUT technology, which are highly beneficial to the development of breakthrough USgFUS products. The USgFUS CMUT probe we have developed has been previously presented [27] . Contrary to the previous article that was dedicated to the probe description and the very first characterizations of the CMUT arrays, this article is devoted to the in-depth characterization of the therapeutic ultrasonic beam and the assessment of the CMUTs viability for hyperthermia applications.
Materials and Methods

Overview of the USgFUS CMUT Probe
The design of the fabricated USgFUS probe (Figure 1(a) ) was driven by two considerations. The first is clearly the acoustic requirements of the target applications. In this study, a frequency of 1 MHz was chosen because of its use in numerous therapeutic treatments [5] . More precisely, sonoporation and the triggered release of thermosensitive liposomes (TSLs) [28] were targeted. Whereas sonoporation generally requires a relatively low peak negative pressure (PNP), the mild hyperthermia required to reach the melting phase transition temperature of the TSLs is more challenging to generate at 1 MHz: [29] showed that this temperature, typically approximately 42˚C, can be reached at 1 MHz, More detailed information about the design stage, the manufacturing process and the choice of the CMUT geometry are given by [27] . 
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Description of the Dedicated US Scanner
Alongside the development of the probe, a dedicated US scanner that was specially designed to deliver FUS sequences and imaging feedback has been manufactured ( Figure 1(b) ). A scheme describing the whole architecture of the scanner is reported in Figure 3 . In red is drawn the electronic circuitry dedicated to High Frequency imaging, whereas in blue is represented the one related to LF emission. There is one master FPGA that controls each FPGA embedded on each HF board through a cPCI backplane. A PC controller drives the platform through an USB link and receives RF signals from the beamforming unit.
The two modalities can be used independently or simultaneously using specific software. The latter is split into three windows, one for each modality and one setting window to set the electrical and acoustical parameters. On the imaging side-which is not extensively described here because it is outside the scope of this article (more information in [32] )-the reconstructed B mode image is displayed with the classical setting parameters (contrast, brightness, gain, specific RF line display). The beamforming process is a classical delay-and-sum, with tunable frequency, transmit and receive apertures.
The current scanner manages 64 HF imaging channels but can be extended to 128 channels by duplicating the electronic Tx/Rx boards. The HF 64 transmitting boards are able to produce 3-state coded pulses on 64 independent and Open Journal of Applied Sciences 
Self-Heating Assessment
The self-heating of the CMUT transducers was assessed by two thermistors embedded into the probe. Each of them is inserted into the silicon coating, between the low-frequency transducers (see Figure 2) . At a given time, the temperature is measured through the resistance value of the two thermistors. At this step of the development, the temperature variations were recorded and stored manually. In order to follow the temperature variation against time, the internal clock of the computer was used to increment at the right value the sampling times.
Hydrophone Measurement
The majority of the characterizations reported hereafter were based on a hydrophone setup. The probe was placed in front of a water tank where a specific 
Simulation
To provide a baseline to assess the quality of the whole probe with respect to the designed one, the measured pressure fields were compared with the simulated ones. The goal is to compare the spatial distributions of the pressure fields but not the absolute pressure amplitude because we had no significant foreknowledge of the average displacement of the membranes. 
Temperature Elevation Measurement
To measure the temperature elevation produced by the probe at the focal spot, a setup adapted from the one proposed by [36] thermocouple was not programmable, the temperature values were manually stored. As for the measure of temperature inside the probe, the sampling time of the temperature was incremented by using the internal clock of the computer.
Results
Validation of the Pressure Field
The ) having a pressure magnitude greater than or equal to half the maximum pressure (isolines at half the maximum pressure are represented by the dashed lines in Figure 5 ). Thereby, the focal spot volume was estimated to be 18.5 mm 3 and 205 mm 3 with and without electronic focusing, respectively.
Variation of the Pressure Amplitude as a Function of VAC/VDC
After the validation of the pressure field, the major challenge of characterizing the therapeutic US beam was naturally the quantification of the maximum pressure delivered by the probe and thereby its ability or lack thereof to meet the requirements imposed by the two target applications. For this purpose, the hydrophone was carefully placed in the focal spot to look for the maximum output 
Variation of the Maximum Pressure with the Frequency
Before the use of the probe with actual emitting sequences, we measured, at the focal point, the maximum pressure amplitude as a function of the ultrasonic frequency. To this end, the hydrophone was set in the focal spot, and V AC and V DC were set to the values that previously delivered the maximum pressure amplitude, i.e. 80 V (maximum expected PTP amplitude delivered by the US scanner) and 110 V, respectively. The pressure amplitude was then recorded, as well as the effective emitter V AC (measured at the emitters output).
10 cycles of a sine wave with a 1 kHz PRF were still used, and the ultrasonic frequency was swept from 800 kHz to 1.3 MHz. Outside this frequency range, the pressure amplitude rapidly collapses because of the electrical components bandwidths and narrow impedance matching. The results are reported in Figure   7 . As one can note, the optimal emitting frequency is approximately 1.25 MHz, with an effective PTP emitter V AC of 87 V, a PTP of 3.6 MPa (PNP 1.5 MPa), and a more linear ultrasonic signal (second harmonic at −16 dB).
Mild-Hyperthermia at the Focal Point
Once the plain functionality of the therapeutic US module has been demonstrated, the probe was tested under the actual insonification sequences required by the target applications. The goal of this measurement was to assess its ability to increase the temperature in glycerol. 
Preliminary Study of Reliability
Different from the imaging short pulses, the long burst insonification sequences required by therapeutic applications are very demanding of the transducers. For these reasons, it is necessary to verify the viability of the employed technology for a relatively long duration. Potential failures may be engendered by charges trapped in the CMUT dielectric layers, thermal effects, or mechanical strain. For these reasons, the probe reliability was checked for 100 minutes of intermittent therapeutic exposure (15 minutes of emission and 5 minutes without emission, repeated 5 times) to mimic actual operation. The CMUT transducers were excited with a command value of V AC = 80 V pp , V DC = 100 V, 40% DC, 1 kHz PRF, at 1 MHz. This represents 1.8 × 109 displacement cycles and a cumulative actuation time of 30 minutes. Three different parameters were simultaneously analyzed: the robustness of the US scanner by recording the delivered V AC amplitude, the robustness of the probe by recording the delivered pressure, and the internal self-heating through the embedded thermistors. To avoid any damage to the hydrophone, which is not suitable for long burst measurements, it was placed far away from the focal spot and out of the probe axis to lower the total energy deposited on the tip. Therefore, only the pressure amplitude variation was investigated to assess the stability of our probe, and the results are reported in Figure 9 . The pressure and voltage amplitudes are normalized by their respective maximum values. 
Discussion
FUS Pressure Field
The nearly perfect matching between the measured and simulated pressure fields validates by itself the good functionality of all the LF transducers, both focusings provided by the US scanner and the mechanical frame, and the manufacturing of the probe. The coating of silicone rubber, which appeared to be a critical step because of the probe shape, does not seem to impact the CMUT cell behavior.
Without the use of electronic focusing, one can nevertheless see a slight asymmetry of the focal spot, showing a small behavioral heterogeneity of the CMUT elements.
Our CMUT-based USgFUS probe can be compared with the piezoelectric-based USgFUS probe reported in [25] . As expected by their sharing a similar design, the shape of the focal spot is roughly the same. The main difference is in the dimension of the mainlobe in depth, which is naturally shorter in our case, as the focusing gain is greater. The sidelobes surrounding the mainlobe are due to the constructive interference of the four LF ultrasonic beams. As the total volume of the focal spot is far smaller than that of the targeted tissues, these sidelobes contribute beneficially to the power deposition. Without electronic focusing, the results are quite the same, except for the size of the azimuth, which then exceeds 10 mm.
Depending on the target applications, the probe exhibits good versatility to tune both the insonified volume and the pressure amplitude. For TSL release, one will focus on the pressure amplitude at the expense of the focal spot. In this case, a PTP pressure of 3 MPa can be achieved, which is in line with the minimum target value defined by [29] . This consideration is in agreement with the temperature elevation measured thereafter, since the TSLs melting temperature 
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Considering the inactive surface between each CMUT cell, the effective radiation surface is 54% of its piezoelectric counterpart. In future work, a better filling factor should be achieved, and therefore a significant increase of the output pressure is expected. Furthermore, additional progress in the chips homogeneity should enable the use of a more optimized bias voltage and thereby lead to a better transmit sensitivity as well.
The optimal emitting frequency is close to 1 MHz, precisely at 1.25 MHz with a maximum PTP pressure of approximately 3.6 MPa. This increase in the PTP pressure amplitude is due to the symmetrization of the signal because of the linearization of the CMUT response with the frequency. Figure 10 reports the harmonic distortion HD3 of the pressure signal, which is defined as 
where A i is the signal amplitude of the i th harmonic component and n is the highest considered harmonic. One can note that although the emitting signals are increasingly distorted with the frequency, the CMUT behavior is increasingly linear. The higher frequencies being closer to the center frequency of the transducers could explain this behavior, as already shown by [37] . Furthermore, the addition of the inductance could linearize the CMUT behavior in a similar way to the harmonic compensation proposed by [38] . This aspect needs to be investigated more deeply. Unfortunately, the electronic drivers embedded in the current US scanner are unable to supply the average power required to fire a long duty cycle at this optimal frequency of 1.25 MHz. This is why this operating point has not been exploited yet. Nevertheless, we are strongly confident that future improvements of the scanner capabilities will easily lead to significantly better performance.
Mild Hyperthemia
As predicted from the previously obtained results on the pressure field, the CMUT probe is able to induce the temperature elevation required to reach the TSLs melting temperature, at least in our in vitro setup. The maximum temperature elevation is approximately 7.5˚C, which means that one could afford to slightly defocus the US beam to increase the insonified volume. Furthermore, [39] showed that the mean absorption coefficient of human soft tissues is approximately 0.54 dB/cm (or 6.2 Np/m) at 1 MHz, higher than that of glycerol (3.6 Np/(m•MHz)). This means that even if an in vivo evaluation will introduce thermal dissipation due to blood perfusion, we could still expect good performance on small animals, depending on the insonified tissue.
Pseudo-Static Use of CMUT Transducers
As stated in the description of the probe, CMUT cells were designed to use them at below their resonant frequency in fluid. From the results presented here and the pressure amplitudes radiated by the probe, this approach seems perfectly valid. It would be instructive to continue progress in this direction, especially for the development of multi-frequency ultrasonic devices where the resonant frequency could be used for one purpose and the pseudo-static emission could be exploited for therapeutic modalities. This aspect, which is specific to the CMUT technology, will be more precisely addressed in a forthcoming study.
Reliability
At the current stage of development of the CMUT transducers, reliability considerations are almost as important as the intrinsic acoustic performances. Particularly for therapeutic applications where long burst sequences are fired, the aging of the device is a critical aspect for the technology. For instance, the trapping of charges may occur in the dielectric layers compounding the CMUT transducers, which could lead to a spurious shift in the vibrating operation point. Considering the relatively high pressure and duty cycles involved, this could quickly result in safety issues for the patient. In the results we presented, though, no significant variation in the pressure amplitude is observed.
Conversely, one of the key aspects of the CMUT transducers is the validation of their expected low self-heating. This could prove to be a breakthrough in the field of therapeutic transduction. In the preliminary test that we carried out for 100 minutes, a total temperature elevation of 3˚C was measured using the embedded thermistors. This is an insignificant rise, and in any case, it would not 
Conclusions
This article described the in vitro characterization of an USgFUS CMUT probe for targeted therapy applications, connected to its dedicated US scanner. The different experimental results from this study are all consistent with the target performances and the simulated results. Measurements on xenograft living mice need to be performed to validate the heating capabilities of the probe for TSL release and sonoporation. The device showed good signs of reliability during demanding excitation bursts. Note that all the results have been obtained on the very first prototype made, which is very satisfactory if we consider the relative level of complexity of the device. This is particularly encouraging for further developments and highlights the potential of the CMUT technology for the development of multi-frequency USgFUS probes.
In this regard, there is plenty of room for improvement in several aspects. Upgrading the current US scanner could provide the possibility to sustain CW therapeutic operation at higher excitation voltages, and adding LF channels could facilitate the electronic focusing of the FUS beam. These improvements could lead to outdating the concave shape of the probe and thereby allow the use of a single monolithic chip embedding all of the LF arrays and the imaging array. The compactness of the device and its exploitation would be greatly facilitated, especially for small animal purposes.
